• 2020-03-24

  • Covid-19 Coronavirus HydroxyChloroquine
  • Paris, France

HydroxyChloroquine Sulfate free of charge PDE and OEL monographs to support the fight versus Covid-19

As responsible player in the European healthcare system, we have organized ourselves to meet our essential tasks, in particular to ensure availability and safety of health products and treatments in the exceptional context of the COVID-19 epidemic.

We have decided to offer hydroxychloroquine CAS number 747-36-4

   Permitted Daily Exposure monographs and Occupational Exposure Limit assessments

   free of charge upon request

   to accompany European and international pharmaceutical manufacturing sites that are requisitioned to produce emergency finished products based on hydroxychloroquine sulfate API.

Our team remains mobilized in remote working mode and all have access to their email and company data, but will continue to respond to your requests in accordance with national recommendations, in order to preserve everyone’s health.

Finally, we salute the doctors, nurses, first responders and ordinary people who work hard to help their neighbours and communities in distress. We admire their courage, applaud their sacrifices and be inspired by their example.

Stay safe, wash your hands

 

WHO Covid-19 updates

Covid-19 Live data worldwide